INVENTIVA PHARMA
Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology. They have built a pipeline backed by a discovery engine with an extensive library of proprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
INVENTIVA PHARMA
Industry:
Biopharma Biotechnology Clinical Trials Medical Medical Device
Founded:
2011-01-01
Address:
Daix, Bourgogne, France
Country:
France
Website Url:
http://www.inventivapharma.com
Total Employee:
101+
Status:
Active
Contact:
+33 (0)3 80 44 75 00
Email Addresses:
[email protected]
Total Funding:
139.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Nginx
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Inventiva Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Inventiva Pharma
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Inventiva Pharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Inventiva Pharma
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Inventiva Pharma
AbbVie
AbbVie investment in Grant - Inventiva Pharma
Sofinnova Partners
Sofinnova Partners investment in Post-IPO Equity - Inventiva Pharma
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Inventiva Pharma
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Inventiva Pharma
BVF Partners
BVF Partners investment in Post-IPO Equity - Inventiva Pharma
Official Site Inspections
http://www.inventivapharma.com Semrush global rank: 2.29 M Semrush visits lastest month: 8.22 K
- Host name: vs16.mygoldennetwork.cognix-systems.net
- IP address: 146.59.140.137
- Location: Norway
- Latitude: 59.9452
- Longitude: 10.7559
- Timezone: Europe/Oslo
